We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current UNCY market cap is 55.73M. The company's latest EPS is USD -3.1356 and P/E is -1.47.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9.2M | -7.4M | -6.25M | -9.26M | -7.99M |
| Net Income | -21.17M | 8.97M | -4.1M | -21.53M | 570k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 951k | 675k | 0 |
| Operating Income | -2.02M | -8.98M | -18.05M | -20.77M | -32.12M |
| Net Income | -2.26M | -10.02M | -18.06M | -31.41M | -37.82M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 52.39M | 44.7M | 38.57M | 31.67M | 27.95M |
| Total Liabilities | 30.65M | 13.36M | 10.72M | 24.24M | 16.68M |
| Total Equity | -24.46M | -14.85M | 27.85M | 7.43M | 11.27M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 204k | 18.74M | 2.82M | 14.19M | 31.67M |
| Total Liabilities | 2.88M | 2.26M | 3.28M | 18M | 24.24M |
| Total Equity | -2.67M | 16.48M | -466k | -3.81M | 7.43M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -6.46M | -12.78M | -22.03M | -28.58M | -8.9M |
| Investing | -6k | -26k | -50k | -72k | -16k |
| Financing | 45.69M | 44.88M | 44.72M | 45.09M | 2.55M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -1.46M | -5.77M | -15.65M | -18.28M | -28.58M |
| Investing | N/A | -29k | -2k | -12k | -72k |
| Financing | 1.44M | 22.38M | -471k | 27.54M | 45.09M |
| Market Cap | 55.73M |
| Price to Earnings Ratio | -1.47 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.13 |
| Price to Book Ratio | 7.5 |
| Dividend Yield | - |
| Shares Outstanding | 12.06M |
| Average Volume (1 week) | 783.14k |
| Average Volume (1 Month) | 1.66M |
| 52 Week Change | -2.37% |
| 52 Week High | 11.00 |
| 52 Week Low | 2.02 |
| Spread (Intraday) | 0.01 (0.21%) |
| Company Name | Unicycive Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.unicycive.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
